Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Susceptibility locus for Alzheimer's disease on chromosome 10.

Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, Shears S, Booth J, DeVrieze FW, Crook R, Hamshere M, Abraham R, Tunstall N, Rice F, Carty S, Lillystone S, Kehoe P, Rudrasingham V, Jones L, Lovestone S, Perez-Tur J, Williams J, Owen MJ, Hardy J, Goate AM.

Science. 2000 Dec 22;290(5500):2304-5.

2.

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K, Selkoe DJ, Saunders AJ, Tanzi RE.

Science. 2000 Dec 22;290(5500):2302-3.

3.
4.

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6037-42.

5.

Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography.

Reiman EM, Uecker A, Gonzalez-Lima F, Minear D, Chen K, Callaway NL, Berndt JD, Games D.

Neuroreport. 2000 Apr 7;11(5):987-91.

PMID:
10790869
6.

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M.

Science. 1999 Oct 22;286(5440):735-41.

7.

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P.

Nature. 1999 Jul 8;400(6740):173-7.

PMID:
10408445
8.

Alzheimer's disease.

Reiman EM, Caselli RJ.

Maturitas. 1999 Mar 15;31(3):185-200. Review.

PMID:
10340278
9.

Apolipoprotein E genetic variation and Alzheimer's disease. a meta-analysis.

Rubinsztein DC, Easton DF.

Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):199-209. Erratum in: Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):238.

PMID:
10325447
10.

Mild cognitive impairment: clinical characterization and outcome.

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E.

Arch Neurol. 1999 Mar;56(3):303-8. Erratum in: Arch Neurol 1999 Jun;56(6):760.

PMID:
10190820
11.

The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.

Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN.

Control Clin Trials. 1998 Dec;19(6):604-21.

PMID:
9875839
12.
13.

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.

Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A, Osborne D, Weaver A, Thibodeau SN.

Ann Neurol. 1998 Aug;44(2):288-91.

PMID:
9708558
14.

Preclinical prediction of Alzheimer's disease using SPECT.

Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS.

Neurology. 1998 Jun;50(6):1563-71.

PMID:
9633695
15.

Frequency of stages of Alzheimer-related lesions in different age categories.

Braak H, Braak E.

Neurobiol Aging. 1997 Jul-Aug;18(4):351-7.

PMID:
9330961
16.

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE.

Ann Neurol. 1997 Jul;42(1):85-94.

17.

No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.

Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, Nordberg A.

Arch Neurol. 1997 Mar;54(3):273-7.

PMID:
9074396
18.

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

Fox NC, Freeborough PA, Rossor MN.

Lancet. 1996 Jul 13;348(9020):94-7.

PMID:
8676724
19.

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D.

N Engl J Med. 1996 Mar 21;334(12):752-8.

20.

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al.

Neurology. 1993 Aug;43(8):1467-72.

PMID:
8350998

Supplemental Content

Support Center